- Home
- ENVX vs VCYT Comparison
ENVX vs VCYT Comparison
Compare ENVX & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENVX
- VCYT
- Stock Information
- Founded
- ENVX 2006
- VCYT 2006
- Country
- ENVX United States
- VCYT United States
- Employees
- ENVX N/A
- VCYT N/A
- Industry
- ENVX Industrial Machinery/Components
- VCYT Medical Specialities
- Sector
- ENVX Miscellaneous
- VCYT Health Care
- Exchange
- ENVX Nasdaq
- VCYT Nasdaq
- Market Cap
- ENVX 2.4B
- VCYT 2.9B
- IPO Year
- ENVX N/A
- VCYT 2013
- Fundamental
- Price
- ENVX $8.12
- VCYT $39.25
- Analyst Decision
- ENVX Strong Buy
- VCYT Buy
- Analyst Count
- ENVX 7
- VCYT 9
- Target Price
- ENVX $17.14
- VCYT $43.56
- AVG Volume (30 Days)
- ENVX 7.8M
- VCYT 984.4K
- Earning Date
- ENVX 11-05-2025
- VCYT 11-04-2025
- Dividend Yield
- ENVX N/A
- VCYT N/A
- EPS Growth
- ENVX N/A
- VCYT N/A
- EPS
- ENVX N/A
- VCYT 0.38
- Revenue
- ENVX $30,273,000.00
- VCYT $495,141,000.00
- Revenue This Year
- ENVX $44.18
- VCYT $14.52
- Revenue Next Year
- ENVX $212.03
- VCYT $9.90
- P/E Ratio
- ENVX N/A
- VCYT $103.44
- Revenue Growth
- ENVX 45.98
- VCYT 16.41
- 52 Week Low
- ENVX $4.61
- VCYT $22.61
- 52 Week High
- ENVX $16.49
- VCYT $47.32
- Technical
- Relative Strength Index (RSI)
- ENVX 32.73
- VCYT 53.80
- Support Level
- ENVX $8.56
- VCYT $39.95
- Resistance Level
- ENVX $9.89
- VCYT $43.41
- Average True Range (ATR)
- ENVX 0.73
- VCYT 2.01
- MACD
- ENVX -0.41
- VCYT 0.05
- Stochastic Oscillator
- ENVX 8.45
- VCYT 38.43
About ENVX Enovix Corporation
Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, Norway, the United States, Taiwan, and other regions.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.